메뉴 건너뛰기




Volumn 7, Issue 1, 2012, Pages

A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CISPLATIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN KINASE B; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR B; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLYCOPROTEIN P; MEMBRANE PROTEIN; ONCOPROTEIN; XIAP PROTEIN, HUMAN;

EID: 84856036725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030246     Document Type: Article
Times cited : (57)

References (43)
  • 2
    • 0346238665 scopus 로고    scopus 로고
    • Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
    • Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, et al. (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350: 351-360.
    • (2004) N Engl J Med , vol.350 , pp. 351-360
    • Arriagada, R.1    Bergman, B.2    Dunant, A.3    Le Chevalier, T.4    Pignon, J.P.5
  • 3
    • 2342517421 scopus 로고    scopus 로고
    • Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    • Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350: 1937-1944.
    • (2004) N Engl J Med , vol.350 , pp. 1937-1944
    • Cooper, J.S.1    Pajak, T.F.2    Forastiere, A.A.3    Jacobs, J.4    Campbell, B.H.5
  • 4
    • 0029851252 scopus 로고    scopus 로고
    • Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group
    • Coppin CM, Gospodarowicz MK, James K, Tannock IF, Zee B, et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14: 2901-2907.
    • (1996) J Clin Oncol , vol.14 , pp. 2901-2907
    • Coppin, C.M.1    Gospodarowicz, M.K.2    James, K.3    Tannock, I.F.4    Zee, B.5
  • 5
    • 61349169676 scopus 로고    scopus 로고
    • Mechanisms and consequences of chemotherapy resistance in breast cancer
    • Coley HM, (2009) Mechanisms and consequences of chemotherapy resistance in breast cancer. European Journal of Cancer Supplements 7: 3-7.
    • (2009) EUROPEAN JOURNAL OF CANCER SUPPLEMENTS , vol.7 , pp. 3-7
    • Coley, H.M.1
  • 6
    • 34249321653 scopus 로고    scopus 로고
    • Mechanisms of resistance to cisplatin and carboplatin
    • Stewart DJ, (2007) Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 63: 12-31.
    • (2007) Crit Rev Oncol Hematol , vol.63 , pp. 12-31
    • Stewart, D.J.1
  • 7
    • 0037112433 scopus 로고    scopus 로고
    • Resistance to chemotherapy mediated by TrkB in neuroblastomas
    • Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, et al. (2002) Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 62: 6462-6466.
    • (2002) Cancer Res , vol.62 , pp. 6462-6466
    • Ho, R.1    Eggert, A.2    Hishiki, T.3    Minturn, J.E.4    Ikegaki, N.5
  • 8
    • 0033500322 scopus 로고    scopus 로고
    • Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents
    • Middlemas DS, Kihl BK, Moody NM, (1999) Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J Neurooncol 45: 27-36.
    • (1999) J Neurooncol , vol.45 , pp. 27-36
    • Middlemas, D.S.1    Kihl, B.K.2    Moody, N.M.3
  • 9
    • 77950867351 scopus 로고    scopus 로고
    • TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma
    • Kupferman ME, Jiffar T, El-Naggar A, Yilmaz T, Zhou G, et al. (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29: 2047-2059.
    • (2010) Oncogene , vol.29 , pp. 2047-2059
    • Kupferman, M.E.1    Jiffar, T.2    El-Naggar, A.3    Yilmaz, T.4    Zhou, G.5
  • 10
    • 78049491063 scopus 로고    scopus 로고
    • Overexpression of BDNF and TrkB in human bladder cancer specimens
    • Lai PC, Chiu TH, Huang YT, (2010) Overexpression of BDNF and TrkB in human bladder cancer specimens. Oncol Rep 24: 1265-1270.
    • (2010) Oncol Rep , vol.24 , pp. 1265-1270
    • Lai, P.C.1    Chiu, T.H.2    Huang, Y.T.3
  • 11
    • 33646551440 scopus 로고    scopus 로고
    • The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?
    • Desmet CJ, Peeper DS, (2006) The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life Sci 63: 755-759.
    • (2006) Cell Mol Life Sci , vol.63 , pp. 755-759
    • Desmet, C.J.1    Peeper, D.S.2
  • 12
    • 33845308195 scopus 로고    scopus 로고
    • Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients?
    • Han L, Zhang Z, Qin W, Sun W, (2007) Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients? Med Hypotheses 68: 407-409.
    • (2007) Med Hypotheses , vol.68 , pp. 407-409
    • Han, L.1    Zhang, Z.2    Qin, W.3    Sun, W.4
  • 13
    • 77957131559 scopus 로고    scopus 로고
    • Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC
    • Yilmaz T, Jiffar T, de la Garza G, Lin H, Milas Z, et al. (2010) Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biol Ther 10.
    • (2010) Cancer Biol Ther , vol.10
    • Yilmaz, T.1    Jiffar, T.2    de la Garza, G.3    Lin, H.4    Milas, Z.5
  • 14
    • 77950911629 scopus 로고    scopus 로고
    • Mutual regulation of Src family kinases and the neurotrophin receptor TrkB
    • Huang YZ, McNamara JO, (2010) Mutual regulation of Src family kinases and the neurotrophin receptor TrkB. J Biol Chem 285: 8207-8217.
    • (2010) J Biol Chem , vol.285 , pp. 8207-8217
    • Huang, Y.Z.1    McNamara, J.O.2
  • 15
    • 19344367302 scopus 로고    scopus 로고
    • A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
    • Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL, (2005) A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood 105: 4429-4436.
    • (2005) Blood , vol.105 , pp. 4429-4436
    • Pearse, R.N.1    Swendeman, S.L.2    Li, Y.3    Rafii, D.4    Hempstead, B.L.5
  • 16
    • 79960348852 scopus 로고    scopus 로고
    • KISS1 mediates platinum sensitivity and metastasis in head and neck squamous cell carcinoma
    • Jiffar T, Yilmaz T, Lee J, Hanna E, El-Naggar A, et al. (2011) KISS1 mediates platinum sensitivity and metastasis in head and neck squamous cell carcinoma. Oncogene.
    • (2011) Oncogene
    • Jiffar, T.1    Yilmaz, T.2    Lee, J.3    Hanna, E.4    El-Naggar, A.5
  • 17
    • 74249116204 scopus 로고    scopus 로고
    • Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma
    • Kupferman ME, Jayakumar A, Zhou G, Xie T, Dakak-Yazici Y, et al. (2009) Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma. J Exp Ther Oncol 8: 117-127.
    • (2009) J Exp Ther Oncol , vol.8 , pp. 117-127
    • Kupferman, M.E.1    Jayakumar, A.2    Zhou, G.3    Xie, T.4    Dakak-Yazici, Y.5
  • 18
    • 37549065194 scopus 로고    scopus 로고
    • Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells
    • Li Z, Tan F, Thiele CJ, (2007) Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther 6: 3113-3121.
    • (2007) Mol Cancer Ther , vol.6 , pp. 3113-3121
    • Li, Z.1    Tan, F.2    Thiele, C.J.3
  • 20
  • 21
    • 68149169019 scopus 로고    scopus 로고
    • BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons
    • Almeida S, Laco M, Cunha-Oliveira T, Oliveira CR, Rego AC, (2009) BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons. Neurobiol Dis 35: 448-456.
    • (2009) Neurobiol Dis , vol.35 , pp. 448-456
    • Almeida, S.1    Laco, M.2    Cunha-Oliveira, T.3    Oliveira, C.R.4    Rego, A.C.5
  • 22
    • 44349102029 scopus 로고    scopus 로고
    • Mutant B-RAF mediates resistance to anoikis via Bad and Bim
    • Boisvert-Adamo K, Aplin AE, (2008) Mutant B-RAF mediates resistance to anoikis via Bad and Bim. Oncogene 27: 3301-3312.
    • (2008) Oncogene , vol.27 , pp. 3301-3312
    • Boisvert-Adamo, K.1    Aplin, A.E.2
  • 23
    • 34247214984 scopus 로고    scopus 로고
    • Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis
    • Schmelzle T, Mailleux AA, Overholtzer M, Carroll JS, Solimini NL, et al. (2007) Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc Natl Acad Sci USA 104: 3787-3792.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 3787-3792
    • Schmelzle, T.1    Mailleux, A.A.2    Overholtzer, M.3    Carroll, J.S.4    Solimini, N.L.5
  • 24
    • 4344627055 scopus 로고    scopus 로고
    • Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
    • Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039.
    • (2004) Nature , vol.430 , pp. 1034-1039
    • Douma, S.1    Van Laar, T.2    Zevenhoven, J.3    Meuwissen, R.4    Van Garderen, E.5
  • 25
    • 23844533212 scopus 로고    scopus 로고
    • The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective
    • Geiger TR, Peeper DS, (2005) The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Res 65: 7033-7036.
    • (2005) Cancer Res , vol.65 , pp. 7033-7036
    • Geiger, T.R.1    Peeper, D.S.2
  • 26
    • 79251647522 scopus 로고    scopus 로고
    • Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1
    • Sengupta S, Mantha AK, Mitra S, Bhakat KK, (2011) Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. Oncogene 30: 482-493.
    • (2011) Oncogene , vol.30 , pp. 482-493
    • Sengupta, S.1    Mantha, A.K.2    Mitra, S.3    Bhakat, K.K.4
  • 28
    • 77956044313 scopus 로고    scopus 로고
    • MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy
    • Hoffmann AC, Wild P, Leicht C, Bertz S, Danenberg KD, et al. (2010) MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 12: 628-636.
    • (2010) Neoplasia , vol.12 , pp. 628-636
    • Hoffmann, A.C.1    Wild, P.2    Leicht, C.3    Bertz, S.4    Danenberg, K.D.5
  • 29
    • 74349117865 scopus 로고    scopus 로고
    • Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts
    • Nemati F, Daniel C, Arvelo F, Legrier ME, Froget B, et al. (2010) Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts. Anticancer Drugs 21: 25-32.
    • (2010) Anticancer Drugs , vol.21 , pp. 25-32
    • Nemati, F.1    Daniel, C.2    Arvelo, F.3    Legrier, M.E.4    Froget, B.5
  • 30
    • 78650491562 scopus 로고    scopus 로고
    • Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics
    • Allen KE, Weiss GJ, (2010) Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 9: 3126-3136.
    • (2010) Mol Cancer Ther , vol.9 , pp. 3126-3136
    • Allen, K.E.1    Weiss, G.J.2
  • 32
    • 0038193551 scopus 로고    scopus 로고
    • P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation
    • Yague E, Armesilla AL, Harrison G, Elliott J, Sardini A, et al. (2003) P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem 278: 10344-10352.
    • (2003) J Biol Chem , vol.278 , pp. 10344-10352
    • Yague, E.1    Armesilla, A.L.2    Harrison, G.3    Elliott, J.4    Sardini, A.5
  • 33
    • 28544432478 scopus 로고    scopus 로고
    • Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
    • Baker EK, Johnstone RW, Zalcberg JR, El-Osta A, (2005) Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Oncogene 24: 8061-8075.
    • (2005) Oncogene , vol.24 , pp. 8061-8075
    • Baker, E.K.1    Johnstone, R.W.2    Zalcberg, J.R.3    El-Osta, A.4
  • 34
    • 78449290132 scopus 로고    scopus 로고
    • Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance
    • Huo H, Magro PG, Pietsch EC, Patel BB, Scotto KW, (2010) Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance. Cancer Res 70: 8726-8735.
    • (2010) Cancer Res , vol.70 , pp. 8726-8735
    • Huo, H.1    Magro, P.G.2    Pietsch, E.C.3    Patel, B.B.4    Scotto, K.W.5
  • 35
    • 0030722392 scopus 로고    scopus 로고
    • Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance
    • Kantharidis P, El-Osta A, deSilva M, Wall DM, Hu XF, et al. (1997) Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin Cancer Res 3: 2025-2032.
    • (1997) Clin Cancer Res , vol.3 , pp. 2025-2032
    • Kantharidis, P.1    El-Osta, A.2    deSilva, M.3    Wall, D.M.4    Hu, X.F.5
  • 36
    • 76749116065 scopus 로고    scopus 로고
    • CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients
    • Sharma G, Mirza S, Parshad R, Srivastava A, Datta Gupta S, et al. (2010) CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem 43: 373-379.
    • (2010) Clin Biochem , vol.43 , pp. 373-379
    • Sharma, G.1    Mirza, S.2    Parshad, R.3    Srivastava, A.4    Datta Gupta, S.5
  • 37
    • 19944432172 scopus 로고    scopus 로고
    • Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas
    • Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, et al. (2005) Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 24: 165-177.
    • (2005) Oncogene , vol.24 , pp. 165-177
    • Schulte, J.H.1    Schramm, A.2    Klein-Hitpass, L.3    Klenk, M.4    Wessels, H.5
  • 38
    • 34247647524 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor: a newly described mediator of angiogenesis
    • Kermani P, Hempstead B, (2007) Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 17: 140-143.
    • (2007) Trends Cardiovasc Med , vol.17 , pp. 140-143
    • Kermani, P.1    Hempstead, B.2
  • 39
    • 37349096959 scopus 로고    scopus 로고
    • Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway
    • Li Z, Thiele CJ, (2007) Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway. Expert Opin Ther Targets 11: 1611-1621.
    • (2007) Expert Opin Ther Targets , vol.11 , pp. 1611-1621
    • Li, Z.1    Thiele, C.J.2
  • 40
    • 33750358311 scopus 로고    scopus 로고
    • Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety
    • Weinreb O, Amit T, Bar-Am O, Sagi Y, Mandel S, et al. (2006) Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. J Neural Transm Suppl pp. 457-465.
    • (2006) J NEURAL TRANSM SUPPL , pp. 457-465
    • Weinreb, O.1    Amit, T.2    Bar-Am, O.3    Sagi, Y.4    Mandel, S.5
  • 41
    • 49849101588 scopus 로고    scopus 로고
    • Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells
    • Zhu N, Gu L, Li F, Zhou M, (2008) Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells. Mol Cancer Ther 7: 1101-1109.
    • (2008) Mol Cancer Ther , vol.7 , pp. 1101-1109
    • Zhu, N.1    Gu, L.2    Li, F.3    Zhou, M.4
  • 42
    • 0033582929 scopus 로고    scopus 로고
    • Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
    • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
    • (1999) Cell , vol.96 , pp. 857-868
    • Brunet, A.1    Bonni, A.2    Zigmond, M.J.3    Lin, M.Z.4    Juo, P.5
  • 43
    • 51349111250 scopus 로고    scopus 로고
    • Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
    • Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, et al. (2008) Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest 118: 3051-3064.
    • (2008) J Clin Invest , vol.118 , pp. 3051-3064
    • Kinkade, C.W.1    Castillo-Martin, M.2    Puzio-Kuter, A.3    Yan, J.4    Foster, T.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.